XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Note 8 - Warrants
3 Months Ended
Mar. 31, 2023
Notes to Financial Statements  
Class of Warrant or Right [Text Block]

8.

WARRANTS  

 

The changes in warrants are as follows:

 

   

Number of

warrants

   

Weighted

average

exercise price

 

Warrants outstanding, December 31, 2021, December 31, 2022 and March 31, 2023

    17,400,000     $ 0.28  

 

Details of warrants outstanding as at March 31, 2023 are as follows:

 

Exercise price

   

Number of

warrants

outstanding

 

Expiry date

 

Number of

warrants

exercisable

  

Remaining

contractual life

(years)

 
                 
$1.00 

(CAD)

  4,900,000 

April 19, 2023(2)

  4,900,000   0.05 
$0.001(1) 

(USA)

  12,500,000 

June 4, 2025

  -   2.18 
                 
      17,400,000    4,900,000     

 

 

(1)

No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per CTI’s 5-year proformas, or 2) listing on a major US exchange, or 3) change of control.

 

(2)

Expired subsequent to March 31, 2023